DFDVW vs REGN · rev $2.1M vs P/E 14, rev $14.34B
DeFi Development Corp. Warrant (DFDVW) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
DeFi Development Corp. Warrant (DFDVW) common stock listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DFDVW revenue for 2024-12-31 was $2.1M. Net income was -$2.7M. Revenue was up 4.8% from 2023-12-31 to 2024-12-31. DFDVW currently screens at market cap $0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DFDVW currently screens at market cap $0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DFDVW and REGN stock pages for the full models.
Not investment advice.